Antares Vision Group and Edgyn, a leading brand protection expert provider that created the patented ADFIRMIA™ digital fingerprinting technology, today announced a strategic alliance partnership to deliver the most advanced brand protection and product authentication suite with a focus on the pharmaceutical industry.

Emidio Zorzella, AVG Chairman and Co-CEO: “This acquisition will allow us to enter a new multi-billion-dollar market – Returnable Asset Management, enabling the upstream integration of our end-to-end digital solution, expanding our presence into new industry verticals and enlarging our customer base with large scale Fortune 1000 recognized companies”.

Antares Vision Group and rfxcel have announced an EPCIS Center of Excellence (COE) to help the pharmaceutical industry prepare for U.S. Drug Supply Chain Security Act (DSCSA) serialization requirements that will take effect in less than two years.

Antares Vision Group, announced today that its subsidiary rfxcel has signed a five-year cooperative agreement with the Lebanese Republic’s Ministry of Public Health to provide a GS1-compliant Traceability Hub to secure the country’s entire pharmaceutical supply chain.